Table 4 Multivariate analysis for overall survival and tumor recurrence, including age, novel grade and FIGO stage in EAC*.

From: Grading of endocervical adenocarcinoma: a novel prognostic system based on tumor budding and cell cluster size

 

Exp(B) (95% CI)

P

Overall survival

  Age (>46 yr vs ≤46 yr)

3.655 (1.194–11.20)

0.023

  Novel grade (G1/2 vs G3)

1.899 (1.055–3.421)

0.033

  FIGO stage (II–IV vs I)

2.435 (1.391–4.260)

0.002

Tumor recurrence

  Age (>46 vs ≤46 yr)

2.061 (0.934–4.550)

0.073

  Novel grade (G1/2 vs G3)

1.787 (1.138–2.805)

0.012

  FIGO stage (II–IV vs I)

2.368 (1.529–3.666)

<0.001

  1. *Annotation: The algorithm for novel grade and related scores is given in Table 1.
Back to article page